|
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Basic information |
| Product Name: | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid | | Synonyms: | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid;3,23-Dioxocycloart-24-en-26-oic acid;(24E)-3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid;19-cyclolanost-24-en-26-oic acid;23-Dioxo-9;9,19-Cyclolanost-24-en-26-oic acid, 3,23-dioxo-, (24E)- | | CAS: | 870456-88-5 | | MF: | C30H44O4 | | MW: | 468.67 | | EINECS: | | | Product Categories: | | | Mol File: | 870456-88-5.mol |  |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Usage And Synthesis |
| Description | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid inhibits the MRCKα kinase with Kd50 of 3.0 uM, it also inhibits the MRCKβ kinase with Kd50 of 3.2 uM; the role of Kinases in cancer onset and progression has made kinases a target for the control of some cancers, suggests that it may possess anticancer activity. |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Preparation Products And Raw materials |
|
